Browse EX-10 agreements

---

Exhibit 10.3

NOTICE OF GRANT

CASH INCENTIVE UNITS

ANTERIS TECHNOLOGIES GLOBAL CORP. EQUITY INCENTIVE PLAN

(AUSTRALIA SERVICE PROVIDER)

Anteris Technologies Global Corp., a Delaware corporation (the “Company”), has awarded to Participant, as identified below, the number of cash incentive units (the “Units”, and each such unit, an “Unit”) set forth below. The Units are subject to all of the terms and conditions as set forth in this Notice of Grant (this “Notice”) as well as in the Company’s Equity Incentive Plan (the “Plan”) and the Service Provider Cash Incentive Unit Agreement (the “Agreement”), both of which are attached hereto and incorporated in their entirety. For purposes of clarity, the Units shall constitute an “other award” within the meaning of Section 9 of the Plan and shall be settled exclusively in cash. Capitalized terms not explicitly defined in this Notice but defined in the Plan or the Agreement will have the same definitions as in the Plan or the Agreement. In the event of any conflict between the terms of the Award and the Plan, the terms of the Plan will

…

CONSULTING SERVICES AGREEMENT

THIS AGREEMENT(the “Agreement”) is made effective as of July 15, 2026 (the “Effective Date”) by and between SAVARA INC., a Delaware corporation having a principal place of business at One Summit Square, 1717 Langhorne Newtown Rd., Suite 300, Langhorne, PA 19047 (“Savara”), and David Lowrance, an individual having a principal place of business at [redacted] (“Consultant”).

BACKGROUND:

A.Savara is a pharmaceutical development company engaged in the business of developing and commercializing biotechnology and pharmaceutical products with a focus on pulmonary diseases (the “Field”).

B.Consultant has expertise relevant to Savara’s work in the Field.

C.Savara now desires to engage Consultant to provide services on and subject to the terms and conditions set forth in this Agreement.

NOW, THEREFORE,intending to be legally bound, the parties agree as follows:

1. Consulting Services.

1.1. Consultant will provide the services described on the attached Schedule A(the “Services”) to Savara or its affiliates.

…

CHANGE IN CONTROL AGREEMENT

This Change in Control Agreement (the “Agreement”) is entered into as of the 7th day of August 2026, by and between SINTX Technologies, Inc., together with its successors and assigns, the “Company”, and Kevin Trask, the Company’s Chief Financial Officer, (the “Executive”).

WHEREAS, the Executive is the Chief Financial Officer of the Company;

WHEREAS, the Company recognizes that the Executive’s service to the Company is very important to the future success of the Company;

WHEREAS, Executive desires to enter into this Agreement to provide Executive with certain financial protection in the event Executive’s employment terminates under specified circumstances in connection with a Change in Control of the Company; and

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company to enter into this Agreement.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Executive agree as follows:

1. Definitions.

…

BFA MASTER SERVICES AGREEMENT

among

Each BFA Recipient Listed in Exhibit A,

BlackRock Fund Advisors

and

The Bank of New York Mellon

Dated as of October 24, 2023

---

TABLE OF CONTENTS

1.	BACKGROUND AND STRUCTURE	1
2.	SERVICE PRINCIPLES	2
3.	CUSTODY SERVICES	4
4.	FUND ADMINISTRATION AND ACCOUNTING SERVICES	5
5.	TRANSFER AGENCY SERVICES	8

…

Execution Version

REVOLVING CREDIT AGREEMENT

dated as of

April 23, 2026

among

BREC HOLDINGS, LP,
as Borrower,

THE LENDERS PARTY HERETO,

and

WELLS FARGO BANK, N.A.,
as Administrative Agent

---

							TABLE OF CONTENTS
								Page
ARTICLE I							DEFINITIONS	1

…

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made and entered into effective as of August 10, 2026(the “Effective Date”), by and between Ajay Aggarwal, M.D.(the “Executive”) and Cardiff Oncology, Inc., a Delaware corporation (the “Company”).

R E C I T A L S

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, in each case effective as of the Effective Date;

WHEREAS, in connection with the foregoing, Executive shall be required to perform Executive’s duties and obligations hereunder on behalf of the Company, as appropriate, and such duties and obligations shall be enforceable by the Company;

WHEREAS, this Agreement supersedes any and all prior term sheets, employment agreements or similar agreements by and between Executive and the Company.

AGREEMENT

In consideration of the mutual covenants herein contained and the employment of Executive by the Company, the parties agree as follows:

1.

Definition of Terms. The following terms referred to in this Agreement shall have the following meanings:

(a)

…

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made and entered into effective as of August 10, 2026(the “Effective Date”), by and between Mani Mohindru, Ph.D.(the “Executive”) and Cardiff Oncology, Inc., a Delaware corporation (the “Company”).

R E C I T A L S

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, in each case effective as of the Effective Date;

WHEREAS, in connection with the foregoing, Executive shall be required to perform Executive’s duties and obligations hereunder on behalf of the Company, as appropriate, and such duties and obligations shall be enforceable by the Company;

WHEREAS, this Agreement supersedes any and all prior term sheets, employment agreements or similar agreements by and between Executive and the Company.

AGREEMENT

In consideration of the mutual covenants herein contained and the employment of Executive by the Company, the parties agree as follows:

1.

Definition of Terms. The following terms referred to in this Agreement shall have the following meanings:

(a)

…

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made and entered into effective as of August 10, 2026(the “Effective Date”), by and between Joshua Muntner(the “Executive”) and Cardiff Oncology, Inc., a Delaware corporation (the “Company”).

R E C I T A L S

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, in each case effective as of the Effective Date;

WHEREAS, in connection with the foregoing, Executive shall be required to perform Executive’s duties and obligations hereunder on behalf of the Company, as appropriate, and such duties and obligations shall be enforceable by the Company;

WHEREAS, this Agreement supersedes any and all prior term sheets, employment agreements or similar agreements by and between Executive and the Company.

AGREEMENT

In consideration of the mutual covenants herein contained and the employment of Executive by the Company, the parties agree as follows:

1.

Definition of Terms. The following terms referred to in this Agreement shall have the following meanings:

(a)

…

RESTRICTED STOCK UNIT AND STOCK OPTION AGREEMENT

THIS RESTRICTED STOCK UNIT AND STOCK OPTION AGREEMENT (the “Agreement”), made effective as of _____ (the “Date of Grant”), between Helios Technologies, Inc., a Florida corporation (the “Corporation”), and _____ (“Participant”).

WITNESSETH:

WHEREAS, Participant is an employee of the Corporation and/or a subsidiary of the Corporation (“Subsidiary”);

WHEREAS, the Corporation has adopted the Helios Technologies 2023 Equity Incentive Plan (the “Plan”) in order to provide its officers, employees and directors with incentives to achieve long-term corporate objectives; which was adopted by the Board of Directors and approved by the shareholders of the Corporation at the Corporation’s June 2023 Annual Meeting; and

WHEREAS, the Compensation Committee of the Corporation’s Board of Directors desires to grant an award of Restricted Stock Units and Nonqualified Stock Options under the Plan to Participant on the terms and conditions set forth below.

…

EXECUTION VERSION

AMENDED AND RESTATED GUARANTEE AGREEMENT

AMENDED AND RESTATED GUARANTEE AGREEMENT, dated as of June

11, 2026 (as amended, restated, supplemented, or otherwise modified from time to time, this “Guarantee”), made by FRANKLIN BSP REAL ESTATE DEBT, INC., a Maryland corporation (“Guarantor”) in favor of JPMorgan Chase Bank, National Association, a national banking association organized under the laws of the United States (“Buyer”).

RECITALS

…

EXECUTION VERSION

AMENDMENT NO. 1 TO UNCOMMITTED

MASTER REPURCHASE AGREEMENT AND AMENDMENT NO. 1 TO FEE AND PRICING LETTER

AMENDMENT NO. 1 TO UNCOMMITTED MASTER REPURCHASE AGREEMENT AND AMENDMENT NO. 1 TO FEE AND PRICING LETTER, dated as of March 30, 2026 (this“Amendment”), between FBRED REIT JWH SELLER, LLC, a Delaware limited liability company (“Seller”), and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, a national banking association (“Buyer”), and acknowledged and agreed to by FBRED REIT REAL ESTATE DEBT OPCO, LLC, a Delaware limited liability company (“Guarantor”). Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Repurchase Agreement (as defined below).

RECITALS

WHEREAS, Seller and Buyer are parties to that certain Uncommitted Master Repurchase Agreement, dated as of March 18, 2025 (as amended hereby, and as further amended, restated, supplemented or otherwise modified and in effect from time to time, the “RepurchaseAgreement”); and

…

GUARANTEE

GUARANTEE, dated as of June 1, 2026 made by FBRED REIT Real Estate Debt OPCO LLC. ("Guarantor"), a Limited Liability Corporation, in favor of Barclays Bank PLC, Barclays Capital Inc. and Barclays Capital Securities Limited (individually, each a “Barclays Entity” and collectively, "Barclays").

For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Guarantor, intending to be legally bound, agrees as follows.

…